ASSESSMENT OF THE UTILITY OF REPEAT FIBEROPTIC BRONCHOSCOPY IN DIAGNOSIS
评估重复纤维支气管镜检查在诊断中的效用
基本信息
- 批准号:3752175
- 负责人:
- 金额:--
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:AIDS therapy HIV infections biopsy blood disorder blood disorder diagnosis bronchoscopy diagnosis design /evaluation diagnosis quality /standard diagnostic respiratory lavage fiber optics human subject medical records neoplasm /cancer neoplasm /cancer diagnosis neoplasm /cancer therapy relapse /recurrence respiratory disorder diagnosis
项目摘要
Recurrent pulmonary symptoms in immunocompromised (IC) patients are a
common problem, and they pose diagnostic and therapeutic challenges.
Repeat FOB is often performed as it is relatively safe, and more invasive
procedures may be risky or contra-indicated. The purpose of this study
was to evaluate the diagnostic and therapeutic efficacies of repeat FOB in
IC patients. A retrospective chart review was performed for all IC
patients undergoing repeat FOB in our department from 1/1/87 through
6/3092. Patients were classified as having either "persistent" pulmonary
disease (dz) (as documented, and with repeat FOB performed within 3) days
of initial FOB), or "new" dz (as documented, and all repeat FOB performed
after 30 days from the initial FOB). In patients with HIV infection, a
new diagnosis was found in 3/15 repeat FOB (20%) with new dz and 3/25
(12%) with persistent dz (p=NS); change in therapy was initiated in 7/15
repeat FOB (47%) with new dz, and 8/25 (32%) with persistent dz (p=NS).
In hematologic/oncologic disorders, a new diagnosis was found in 6/10
repeat FOB (60%) with new dz, and in 7/32 (22%) with persistent dz
(p=0.03); a change in therapy was initiated in 7/10 repeat FOB (70%) with
new dz, and in 13/32 (41% with persistent dz (p=.11). In patients with
other immunocompromised conditions, a new diagnosis was found in 1/9
repeat FOB (11%) with new dz, and 4/12 (33%) with persistent dz (p=NS); a
change in therapy was initiated in 3/9 repeat FOB (33%) with new dz, and
in 10/12 (83%) with persistent dz (p=0.02). In conclusion, the diagnostic
yield to repeat FOB in patients with HIV infection is equally effective in
the presence of new or persistent dz; in patients with
hematologic/oncologic disorders and new dz, repeat FOB is more likely to
establish a new diagnosis; and in patients with other immunocompromised
conditions, repeat FOB may be useful in guiding therapy.
免疫功能低下(IC)患者的复发性肺部症状是
这是一个常见的问题,也是诊断和治疗的挑战。
重复FOB经常进行,因为它是相对安全的,更具侵入性
手术可能有风险或禁忌。 本研究的目的
目的:评价重复FOB对原发性肝癌的诊断和治疗效果。
IC患者 对所有IC进行了回顾性病历审查
从1987年1月1日至1988年12月31日,
6/3092. 患者被归类为“持续性”肺动脉高压,
疾病(dz)(根据记录,并在3天内重复进行FOB)
初始FOB)或“新”dz(如文件所述,并执行所有重复FOB
从最初的FOB起30天后)。 艾滋病毒感染者,
3/15例(20%)重复FOB中发现新诊断,3/25例(20%)为新dz,
(12%)持续性dz(p=NS); 7/15例患者开始改变治疗
新发dz重复FOB(47%),持续dz重复FOB(8/25)(32%)(p=NS)。
在血液学/肿瘤学疾病中,6/10例发现新诊断
新发dz重复FOB(60%),持续dz重复FOB 7/32(22%)
(p=0.03); 7/10例重复FOB(70%)开始改变治疗,
新发DZ和13/32例(41%)持续性DZ(p= 0.11)。 患者
其他免疫功能低下的条件,新的诊断被发现在1/9
新发dz重复FOB(11%),持续dz重复FOB(4/12)(33%)(p=NS); a
在3/9例使用新dz的重复FOB(33%)中开始改变治疗,
10/12例(83%)持续性DZ(p=0.02)。 总之,诊断
艾滋病病毒感染者重复FOB的产量同样有效,
新的或持续性DZ的存在;
血液学/肿瘤学疾病和新发dz,重复FOB更可能
建立一个新的诊断;和其他免疫功能低下的患者
条件下,重复FOB可能有助于指导治疗。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
F P OGNIBENE其他文献
F P OGNIBENE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('F P OGNIBENE', 18)}}的其他基金
PULMONARY INFECTION IN PATIENTS WITH CHRONIC GRANULOMATOUS DISEASE (CGD)
慢性肉芽肿病 (CGD) 患者的肺部感染
- 批准号:
2456662 - 财政年份:
- 资助金额:
-- - 项目类别:
DIAGNOSIS OF PNEUMOCYSTIS CARINII BY INDUCED SPUTUM IN IMMUNOSUPPRESSED CHILDREN
免疫抑制儿童卡氏肺囊虫的诱导痰诊断
- 批准号:
3874251 - 财政年份:
- 资助金额:
-- - 项目类别:
ASSESSMENT OF TOLERANCE OF AEROSOLIZED PENTAMIDINE IN PEDIATRIC PATIENTS
儿科患者雾化喷他脒的耐受性评估
- 批准号:
3853058 - 财政年份:
- 资助金额:
-- - 项目类别:
PNEUMOCYSTIS CARINII BY INDUCED SPUTUM IN IMMUNOSUPPRESSED PEDIATRIC PATIENTS
免疫抑制儿科患者诱发痰引起的卡氏肺囊虫
- 批准号:
6103548 - 财政年份:
- 资助金额:
-- - 项目类别:
PNEUMOCYSTIS CARINII BY INDUCED SPUTUM IN IMMUNOSUPPRESSED PEDIATRIC PATIENTS
免疫抑制儿科患者诱发痰液感染卡氏肺囊虫
- 批准号:
5201067 - 财政年份:
- 资助金额:
-- - 项目类别:
ASSESSMENT OF IFOSFAMIDE-INDUCED CARDIOVASCULAR DYSFUNCTION
异环磷酰胺引起的心血管功能障碍的评估
- 批准号:
3853059 - 财政年份:
- 资助金额:
-- - 项目类别:
PNEUMOCYSTIS CARINII BY INDUCED SPUTUM IN IMMUNOSUPPRESSED PEDIATRIC PATIENTS
免疫抑制儿科患者诱发痰引起的卡氏肺囊虫
- 批准号:
2571297 - 财政年份:
- 资助金额:
-- - 项目类别:
ASSESSMENT OF THE UTILITY OF REPEAT FIBEROPTIC BRONCHOSCOPY IN DIAGNOSIS
评估重复纤维支气管镜检查在诊断中的效用
- 批准号:
2571308 - 财政年份:
- 资助金额:
-- - 项目类别:
PHASE I, PILOT STUDY OF NEW NEBULIZATION TECHNIQUE FOR PENTAMIDINE AEROLIZATION
第一阶段,喷他脒雾化新雾化技术的试点研究
- 批准号:
3774438 - 财政年份:
- 资助金额:
-- - 项目类别:
PNEUMOCYSTIS CARINII BY INDUCED SPUTUM IN IMMUNOSUPPRESSED CHILDREN
免疫抑制儿童中诱发痰引起的卡氏肺囊虫
- 批准号:
3837915 - 财政年份:
- 资助金额:
-- - 项目类别:
相似海外基金
A targeted combination intervention approach for acute HIV infections to curb the explosive epidemic among high-risk populations in Indonesia
针对急性艾滋病毒感染的针对性组合干预方法,遏制印度尼西亚高危人群的爆发性流行
- 批准号:
MR/V035304/1 - 财政年份:2022
- 资助金额:
-- - 项目类别:
Research Grant
IMPAACT RELATED PROTOCOLS FOR THE RESEARCH ON TREATMENT, PREVENTION, DIAGNOSIS AND EPIDEMIOLOGY OF HIV INFECTIONS
HIV 感染的治疗、预防、诊断和流行病学研究的影响相关方案
- 批准号:
10369859 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Determining the mechanisms of vascular CD8 T cell activation in CMV and HIV infections
确定 CMV 和 HIV 感染中血管 CD8 T 细胞激活的机制
- 批准号:
10461964 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Determining the mechanisms of vascular CD8 T cell activation in CMV and HIV infections
确定 CMV 和 HIV 感染中血管 CD8 T 细胞激活的机制
- 批准号:
10326617 - 财政年份:2021
- 资助金额:
-- - 项目类别:
Combination HIV Prevention: Using anti-retroviral and anti-inflammatory medications to prevent new HIV infections
HIV 联合预防:使用抗逆转录病毒和抗炎药物预防新的 HIV 感染
- 批准号:
404211 - 财政年份:2018
- 资助金额:
-- - 项目类别:
Operating Grants
BALTIMORE: PROJECTS TO REDUCE HIV INFECTIONS AND IMPROVE ENGAGEMENT IN HIV MEDICAL CARE AMONG MSM
巴尔的摩:减少艾滋病毒感染和提高男男性行为者参与艾滋病毒医疗护理的项目
- 批准号:
9078083 - 财政年份:2015
- 资助金额:
-- - 项目类别:
Health Department Demonstration Projects to Reduce HIV Infections and Improve Engagement in HIV Medical Care among Men Who Have Sex with Men (MSM) and Transgender Persons
卫生部示范项目旨在减少男男性行为者 (MSM) 和跨性别者的艾滋病毒感染并提高他们对艾滋病毒医疗护理的参与度
- 批准号:
9079323 - 财政年份:2015
- 资助金额:
-- - 项目类别:
REDUCING HIV INFECTIONS AND IMPROVING ENGAGEMENT IN HIV MEDICAL CARE AMONG MSM IN MEMPHIS TN
减少田纳西州孟菲斯市 MSM 的 HIV 感染并提高其对 HIV 医疗护理的参与度
- 批准号:
9079336 - 财政年份:2015
- 资助金额:
-- - 项目类别:
Double-Negative T cells in SIV and HIV Infections
SIV 和 HIV 感染中的双阴性 T 细胞
- 批准号:
8472130 - 财政年份:2012
- 资助金额:
-- - 项目类别:
REDUCING HIV INFECTIONS AMONG COMMERCIAL SEX WORKERS IN GERT SIBANDE DISTRICT TAV
减少格特西班德区 TAV 商业性工作者的艾滋病毒感染
- 批准号:
8532661 - 财政年份:2011
- 资助金额:
-- - 项目类别: